ABBV
Abbvie Inc
NYSE · Biotechnology
$223.43
+4.41 (+2.01%)
S&P 500
Mega-Cap Stocks
Blue Chip Stocks
Biotech Stocks
Healthcare Stocks
Best Dividend Stocks
Highest Dividend Yield
Income Statement
| FY 2026 | FY 2026 | FY 2025 | FY 2025 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | 56.16B | 56.16B | 56.11B | 56.11B | 198.98B |
| Net Income | 4.26B | 4.26B | 3.84B | 3.84B | 7.02B |
| EPS | — | — | — | — | — |
| Profit Margin | 7.6% | 7.6% | 7.2% | 7.2% | 3.5% |
| Rev Growth | +0.1% | +0.1% | +0.1% | +0.1% | +22.6% |
Balance Sheet
| FY 2026 | FY 2026 | FY 2025 | FY 2025 | FY 2025 | |
|---|---|---|---|---|---|
| Total Debt | 188.13B | 188.13B | 188.13B | 188.13B | 49.32B |
| Total Equity | 9.32B | 9.32B | 9.32B | 9.32B | 280.81B |
| D/E Ratio | 20.19 | 20.19 | 20.19 | 20.19 | 0.18 |
Cash Flow
| FY 2026 | FY 2026 | FY 2025 | FY 2025 | FY 2025 | |
|---|---|---|---|---|---|
| EBITDA | 6.64B | 6.64B | 6.30B | 6.30B | 15.75B |
| Free Cash Flow | — | — | — | — | 7.11B |